Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lis Smedegaard Andersen
Response To: ‘Mandatory, Cost-Driven Switching From Originator Etanercept to Its Biosimilar SB4: Possible Fallout on Non-Medical Switching’ by Cantini and Benucci
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
Rheumatology and Therapy
Observational Study of Inflammatory Arthritis Treatment by Etanercept Originator Switched to an Etanercept Biosimilar
Reumatologia
Rheumatology
Allergy
Immunology
Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden
Biologics in Therapy
Prm42 - Cost Model of Switching From Enbrel to Etanercept Biosimilars, for Non Medical Reasons, in Rheumatoid Arthritis Patients in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Real Concern or Just a Hype? – Evidence on Negative Clinical Consequences of Switching From Originator to Biosimilar Based on a Systematic Literature Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Does a Mandatory Non-Medical Switch From Originator to Biosimilar Infliximab Lead to Increased Use of Outpatient Healthcare Resources? A Register-Based Study in Patients With Inflammatory Arthritis
RMD Open
Rheumatology
Allergy
Immunology
SAT0161 Preliminary Real World Data on Switching Patterns Between Etanercept, Its Recently Marketed Biosimilar Counterpart and Its Competitor Adalimumab, Using Swedish Prescription Registry
Switching From Originator Biological Agents to Biosimilars: What Is the Evidence and What Are the Issues?
RMD Open
Rheumatology
Allergy
Immunology
Position on Non-Medical Switching for Diabetes Patients
Journal of Diabetes, Metabolic Disorders & Control
